Sugal & Damani Share Brokers Ltd
₹ 73.0
1.32%
28 Nov
- close price
- Market Cap ₹ 45.6 Cr.
- Current Price ₹ 73.0
- High / Low ₹ 139 / 44.6
- Stock P/E 8.16
- Book Value ₹ 47.0
- Dividend Yield 0.00 %
- ROCE 24.6 %
- ROE 20.2 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 19.9% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 12.8% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.44 | 6.52 | 5.51 | 5.85 | 7.45 | 5.88 | 7.11 | 4.95 | 2.54 | 2.00 | 5.92 | 25.92 | 25.48 | |
| 2.97 | 4.30 | 3.35 | 3.27 | 4.12 | 2.97 | 3.87 | 4.92 | 0.86 | 1.05 | 2.78 | 19.61 | 18.60 | |
| Operating Profit | 0.47 | 2.22 | 2.16 | 2.58 | 3.33 | 2.91 | 3.24 | 0.03 | 1.68 | 0.95 | 3.14 | 6.31 | 6.88 |
| OPM % | 13.66% | 34.05% | 39.20% | 44.10% | 44.70% | 49.49% | 45.57% | 0.61% | 66.14% | 47.50% | 53.04% | 24.34% | 27.00% |
| -0.02 | 0.02 | 0.00 | 0.00 | 0.06 | 0.06 | 0.05 | 0.09 | 0.15 | 0.59 | 0.47 | 0.22 | 0.70 | |
| Interest | 0.25 | 0.61 | 0.52 | 0.55 | 0.49 | 0.54 | 0.67 | 0.33 | 0.00 | 0.01 | 0.59 | 0.14 | 0.09 |
| Depreciation | 0.08 | 0.09 | 0.09 | 0.06 | 0.04 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.06 | 0.08 |
| Profit before tax | 0.12 | 1.54 | 1.55 | 1.97 | 2.86 | 2.40 | 2.60 | -0.23 | 1.81 | 1.51 | 2.99 | 6.33 | 7.41 |
| Tax % | 25.00% | 30.52% | 28.39% | 29.44% | 18.18% | 22.92% | 25.77% | 56.52% | 24.86% | 35.10% | 22.74% | 25.12% | |
| 0.10 | 1.08 | 1.10 | 1.40 | 2.33 | 1.85 | 1.92 | -0.36 | 1.37 | 0.98 | 2.31 | 4.75 | 5.59 | |
| EPS in Rs | 0.16 | 1.73 | 1.76 | 2.24 | 3.73 | 2.96 | 3.07 | -0.58 | 2.19 | 1.57 | 3.70 | 7.60 | 8.95 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 30% |
| 3 Years: | 117% |
| TTM: | 74% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 20% |
| 3 Years: | 51% |
| TTM: | 69% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 61% |
| 3 Years: | 74% |
| 1 Year: | -2% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 13% |
| Last Year: | 20% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.25 | 6.25 | 6.25 | 6.25 | 6.25 | 6.25 | 6.25 | 6.25 | 6.25 | 6.25 | 6.25 | 6.25 | 6.25 |
| Reserves | 1.18 | 2.00 | 3.10 | 5.16 | 7.53 | 8.84 | 10.90 | 10.26 | 11.96 | 12.81 | 15.01 | 19.64 | 23.10 |
| 4.15 | 8.37 | 2.82 | 4.34 | 5.08 | 0.00 | 0.01 | 0.00 | 0.00 | 1.05 | 3.87 | 1.65 | 0.51 | |
| 7.92 | 5.31 | 7.37 | 9.68 | 10.74 | 14.22 | 16.15 | 1.88 | 1.70 | 1.70 | 2.38 | 5.13 | 4.05 | |
| Total Liabilities | 19.50 | 21.93 | 19.54 | 25.43 | 29.60 | 29.31 | 33.31 | 18.39 | 19.91 | 21.81 | 27.51 | 32.67 | 33.91 |
| 0.58 | 0.25 | 0.29 | 0.26 | 0.22 | 0.16 | 0.13 | 0.08 | 0.08 | 0.06 | 0.11 | 0.49 | 0.49 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 |
| Investments | 4.91 | 7.89 | 5.18 | 5.34 | 5.45 | 2.62 | 4.82 | 0.25 | 14.85 | 4.78 | 1.82 | 11.10 | 17.95 |
| 14.01 | 13.79 | 14.07 | 19.83 | 23.93 | 26.53 | 28.36 | 18.06 | 4.98 | 16.90 | 25.58 | 21.08 | 15.47 | |
| Total Assets | 19.50 | 21.93 | 19.54 | 25.43 | 29.60 | 29.31 | 33.31 | 18.39 | 19.91 | 21.81 | 27.51 | 32.67 | 33.91 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.77 | -0.20 | 1.99 | -1.65 | 0.82 | -2.67 | 4.05 | -4.95 | 7.07 | -11.63 | -6.23 | 14.41 | |
| -3.62 | -2.16 | 4.18 | 2.28 | 2.29 | 4.58 | -0.23 | 6.09 | -13.60 | 10.55 | 3.92 | -9.28 | |
| 1.20 | 3.69 | -6.01 | 1.03 | 0.31 | -5.61 | -0.67 | -0.34 | 0.00 | 1.04 | 2.24 | -2.36 | |
| Net Cash Flow | 0.35 | 1.34 | 0.16 | 1.65 | 3.42 | -3.70 | 3.15 | 0.81 | -6.53 | -0.04 | -0.08 | 2.77 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 823.37 | 409.79 | 458.40 | 612.08 | 488.46 | 677.86 | 281.84 | 33.92 | 80.47 | 27.38 | 14.18 | 3.38 |
| Inventory Days | 5,325.09 | 260.76 | ||||||||||
| Days Payable | 547.50 | 90.52 | ||||||||||
| Cash Conversion Cycle | 823.37 | 409.79 | 458.40 | 612.08 | 488.46 | 677.86 | 281.84 | 33.92 | 80.47 | 27.38 | 4,791.77 | 173.62 |
| Working Capital Days | -262.08 | -286.63 | -96.05 | -133.52 | -228.80 | -151.46 | -498.99 | -62.68 | -71.85 | 443.48 | 1,212.15 | 153.07 |
| ROCE % | 3.63% | 15.25% | 14.38% | 18.05% | 19.36% | 17.32% | 20.28% | 0.59% | 10.43% | 7.93% | 15.56% | 24.57% |
Documents
Announcements
-
Newspaper Cutting Of Results
15 Nov - Sugal & Damani published newspaper advertisements of unaudited consolidated and standalone Q2 results for quarter ended 30 Sep 2025.
-
Board Meeting Outcome for Unaudited Financials Results For The Quarter Ended 30/09/2025
14 Nov - Unaudited standalone results and auditors' limited review for quarter ended Sep 30, 2025 approved Nov 14, 2025.
-
Update on board meeting
7 Nov - Board meeting Nov 14, 2025 to approve unaudited Q2 (Sept 30, 2025) results; trading window Oct 1–Nov 16.
-
Update on board meeting
7 Nov - Board meeting on Nov 14, 2025 to approve unaudited Q2 results (ended Sep 30, 2025); trading window closed Oct 1–Nov 16.
-
Board Meeting Intimation for The Quarter Ended 30.09.2025
6 Nov - Board meeting Nov 14, 2025 11:00AM to approve unaudited results quarter ended Sep 30, 2025; trading window Oct 1–Nov 16.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
a) Dealing in shares and other Securities in Secondary Markets
b) Identifying investment avenues and advising on portfolio management
c) Underwriting and broking for New Issues
d) Financial and advisory services, brokerage & distribution of equities, commodities, etc.